Press release
Ankylosing Spondylitis Treatment Market Size, Share, Analysis, Industry Report and Forecast to 2026
A full Report of Global Ankylosing Spondylitis Treatment Market at https://www.omrglobal.com/industry-reports/ankylosing-spondylitis-treatment-market
These market players are making a hefty investment in their R&D sector to perform drug development for the launch of new and advanced drugs for the treatment of this disorder. For instance, in October 2019, Novartis International AG, a pharmaceutical company had received approval from European Commission (EC) to perform the up-titration of Cosentyx (secukinumab) to 300 mg for patients with active ankylosing spondylitis. The approval is based on data from MEASURE 3, a three-year study that identified the efficacy and tolerability of Cosentyx in ankylosing spondylitis patients.
Request a Free Sample of Global Ankylosing Spondylitis Treatment Market @ https://www.omrglobal.com/request-sample/ankylosing-spondylitis-treatment-market
In August 2019, Eli Lilly and Company, an American pharmaceutical company had received the US FDA approval for Taltz (ixekizumab) injection 80 mg/mL for the treatment of adults with active ankylosing spondylitis, also known as radiographic axial spondyloarthritis (r-axSpA). Taltz (ixekizumab) injection 80 mg/mL is the third indication of the Talz which was approved for the treatment of moderate to severe plaque psoriasis in adult patients and then approved in December 2017 for the treatment of psoriatic arthritis.
In August 2019, AbbVie’s Pharmaceutical, a research-based global biopharmaceutical company, had received US FDA approval for RINVOQ (upadacitinib). RINVOQ (upadacitinib) is a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis. In December 2019, RINVOQ (upadacitinib) is proved to be effective in a Phase 2/3 trial shows for the treatment of adults with active ankylosing spondylitis who failed to respond to or are not eligible for non-steroidal anti-inflammatory drugs (NSAIDs).
Current Market Trends Covered in the Market Report.
• North America is anticipated to hold a major market share during the forecast period.
• The rising awareness among people related to the treatment of the ankylosing spondylitis.
• Partnerships, collaborations, and new product launches – key drivers of competition in the market.
Global Ankylosing Spondylitis Treatment Market Segmentation
By Drug
• Secukinumab
• Adalimumab
• Golimumab
• Infliximab
• Etanercept
• Certolizumab Pegol
• Other
Global Ankylosing Spondylitis Treatment Market Segmentation by region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of the Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• AbbVie, lnc.
• Allergen, Inc.
• Amgen, Inc.
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb, Co.
• Cadila Healthcare, Ltd.
• Eli Lilly and Co.
• Endo Health Solutions, Inc.
• F. Hoffmann-La Roche, Ltd.
• Ferring B.V.
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Purdue Pharma L.P.
• Sanofi S.A.
• Torrent Pharmaceuticals, Ltd.
• Valeant Pharmaceuticals International Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/ankylosing-spondylitis-treatment-market
For More Information, Visit https://www.omrglobal.com
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ankylosing Spondylitis Treatment Market Size, Share, Analysis, Industry Report and Forecast to 2026 here
News-ID: 2132036 • Views: …
More Releases from Orion Market Research
Used Cooking Oil Market Development, Industry Trends, Demand and Growth Analysis …
The global Used Cooking Oil (UCO) Market was valued at approximately USD 6.1 billion in 2023 and is projected to reach around USD 11.8 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of about 7.5% from 2024 to 2032.
Used Cooking Oil Market Overview
The Used Cooking Oil Market is gaining traction globally, driven by rising demand for sustainable biofuels, particularly biodiesel. Governments and environmental bodies are…
Loader Buckets Market to see Huge Growth by 2028
Market experts do detailed market study about entire market from several angles to depict the most updated and key market data to form this detailed Loader Buckets Market research report and help startups to reinforce their presence. This report further aims at covering vital data and figures on major areas such Asia Pacific, North America, Middle East, Europe, Latin America and Africa. Business participants can also obtain larger gains as…
Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market…
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry.
Key Players
Belgard
Acme Brick Company
The Belden Brick Company
Wienerberger
Pine Hall Brick
Redland Brick
By Type
General Brick Pavers
Wall…
More Releases for Ankylosing
Ankylosing Spondylitis Medication Market Size And Global Industry Forecast 2034
"As of 2024, the global ankylosing spondylitis (AS) medication market is valued at approximately $5 billion, driven by an increasing prevalence of the condition and a growing awareness of treatment options. The market is projected to reach roughly $9 billion by 2034, reflecting a robust growth trajectory over the next decade. The anticipated Compound Annual Growth Rate (CAGR) for the forecast period from 2025 to 2034 is estimated at around…
Ankylosing Spondylitis Market Surges With The Growing Geriatric Population World …
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Ankylosing Spondylitis Market Size and Its Estimated Growth Rate?
The Ankylosing Spondylitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.…
Ankylosing Spondylitis Uncovered: Market Dynamics and Future Projections
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/2638
Introduction:
The global ankylosing spondylitis market has been on a steady rise, reflecting the growing awareness and prevalence of this inflammatory condition. With a remarkable market size of $5,140.94 million in 2020, the projections indicate a substantial leap to $8,110.59 million by 2030. Ankylosing spondylitis, often misunderstood, is a complex disorder that affects the spine's flexibility and posture, potentially leading to severe complications if not managed effectively.
Unveiling Ankylosing…
Ankylosing Spondylitis Treatment Market to Witness Astonishing Growth by 2029
This Ankylosing Spondylitis Treatment Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Ankylosing Spondylitis Treatment Market study report.…
Ankylosing Spondylitis Market Overview With Detailed Analysis 2022-2028
According to Precision Business Insights (PBI), the latest report, ankylosing spondylitis market is expected to be valued at USD 5,460.5 million in 2022 which is expected to grow at a CAGR of 4.8% over 2022-2028. The primary factors that drive the market are the presence of biosimilars, usage of novel products, and increasing prevalence of ankylosing spondylitis.
View the detailed report description here - https://precisionbusinessinsights.com/market-reports/ankylosing-spondylitis-market/
Retail Pharmacy to Dominate the…
Ankylosing Spondylitis Market Challenges and Investment Opportunities by 2027
Allied Market Research published a report, titled, “Ankylosing Spondylitis Market: Global Opportunity Analysis and Industry Forecast 2020–2027.” According to the report, the global Ankylosing Spondylitis industry garnered $XX billion in 2019, and is expected to generate $xx billion by 2027, witnessing a CAGR of xx% from 2020 to 2027.
Click Here To Access Sample Report https://www.alliedmarketresearch.com/request-sample/10631
Major players analyzed include AbbVie Inc., Janssen Pharmaceuticals Inc., Pfizer Inc., Sandoz International GmbH, Amgen…
